Skip to main content

Irish developer of malaria vaccine wins European Inventor Award
Irish developer of malaria vaccine wins European Inventor Award

Ireland’s Adrian Hill has received the European Patent Office’s European Inventor Award 2026 in the research category for his work developing the R21/Matrix-M malaria vaccine.
The highly effective vaccine achieved roughly 80pc protection in clinical trials, exceeding even World Health Organization (WHO) targets of 75pc. 

Designed for large-scale deployment in lower-income countries, the awarding body noted, the vaccine created by Hill and his team presents more of the malaria-specific protein regions needed to trigger a strong immune response, which offers significantly more protection against the disease than traditional vaccines. 

It costs less than €3 to make per dose and can remain stable for up to two years under standard refrigeration conditions, helping make vaccination programmes more accessible in regions where malaria remains endemic, according to the European Patent Office. 

Commenting on the win, Hill said, “I am delighted to accept this prestigious award on behalf of the many hundreds of people who have contributed to the discovery, development and licensure of our malaria vaccine over the past 12 years.”

Hill’s commitment to malaria research began in Gambia in 1988 when he witnessed the impact the illness can have, particularly on young children. According to the WHO, in 2024 there were 282m cases of malaria causing roughly 610,000 deaths globally. Three-quarters of those reported deaths were in Africa-based children under five. 

The project brought together partners including the University of Oxford, the Serum Institute of India, Novavax, and leading African research centres in Burkina Faso, Kenya, Mali and Tanzania. 
The awards show was held in Berlin; other inventors competing with Hill included Portuguese research finalist Paula Videira and her team, who were nominated for a high-precision antibody that distinguishes cancer cells from healthy tissue.

Finnish physicist Mikko Möttönen was considered for his work developing an ultrasensitive cryogenic microwave sensor that aims to improve quantum computing hardware.

Laura Varley
This article originally appeared on www.siliconrepublic.com and can be found here

You Might Also Be Interested In

  • 4 minute read
  • Published 13/07/2026

Intel announces €5 billion investment to expand European manufacturing output

Intel today announced a €5 billion ($5.7 billion) capital investment at its Leixlip campus in Ireland, marking the next phase in the site’s capacity expansion.

Read more
  • 4 minute read
  • Published 08/07/2026

Dedalus officially opens new Irish headquarters 

Dedalus Ireland today officially opened its new Irish headquarters at Northwood Business Park, Dublin, at an event attended by Peter Burke TD, Minister for Enterprise, Tourism and Employment, alongside Michael Lohan, CEO, IDA Ireland, and Counsellor Edoardo Berionni Berna, Deputy Head of Mission, Embassy of Italy in Ireland

Read more
  • 5 minute read
  • Published 01/07/2026

IDA Ireland reports continued strong investment momentum in H1 2026 in midst of increasing competitive FDI landscape

IDA Ireland today published its results for the first six months of 2026 alongside its Annual Report for 2025, the first since the launch of its Adapt intelligently strategy

Read more